Joseph Vazzano
2018 - AVENUE THERAPEUTICS
In 2018, Joseph Vazzano earned a total compensation of $354.5K as Chief Financial Officer at AVENUE THERAPEUTICS, a 9% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $67,851 |
|---|---|
| Salary | $175,100 |
| Stock Awards | $103,800 |
| Other | $7,777 |
| Total | $354,528 |
Vazzano received $175.1K in salary, accounting for 49% of the total pay in 2018.
Vazzano also received $67.9K in non-equity incentive plan, $103.8K in stock awards and $7.8K in other compensation.
Rankings
In 2018, Joseph Vazzano's compensation ranked 12,831st out of 14,244 executives tracked by ExecPay. In other words, Vazzano earned more than 9.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,831 out of 14,244 | 10th |
Division Manufacturing | 5,188 out of 5,759 | 10th |
Major group Chemicals And Allied Products | 1,951 out of 2,122 | 8th |
Industry group Drugs | 1,672 out of 1,811 | 8th |
Industry Pharmaceutical Preparations | 1,280 out of 1,385 | 8th |
Source: SEC filing on April 30, 2019.
Vazzano's colleagues
We found two more compensation records of executives who worked with Joseph Vazzano at AVENUE THERAPEUTICS in 2018.
News
Abeona Therapeutics CEO Vishwas Seshadri's 2023 pay jumps 90% to $2.8M
March 19, 2024
Abeona Therapeutics CEO Vishwas Seshadri's 2022 pay slips 4% to $1.5M
April 13, 2023
AVENUE THERAPEUTICS CEO Lucy Lu's 2021 pay jumps 144% to $1.1M
November 18, 2022
AVENUE THERAPEUTICS CEO Lucy Lu's 2020 pay falls 31% to $443K
November 23, 2021
AVENUE THERAPEUTICS CEO Lucy Lu's 2019 pay falls 60% to $640K
April 29, 2020
AVENUE THERAPEUTICS CEO Lucy Lu's 2018 pay falls 22% to $1.6M
April 30, 2019